[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368336-105":59,"doc-detail-368336-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pathogenic-germline-variants-in-cancer-predisposition-genes-in-patients-with-multiple-primary-cancers-in-an-asian-population-and-the-role-of-extended-panel-genetic-testing","Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing","","Multiple primary cancers (MPC) can signal an underlying hereditary cancer predisposition syndrome, yet available evidence is limited on how often pathogenic germline variants (PGVs) are found and which testing panel size is optimal. This retrospective single-centre analysis evaluated the prevalence of MPC, the spectrum of PGVs, and cancer patterns. Most patients received 49-gene testing, while selected MPC cases underwent extended testing with 216 genes. Extended panels increased PGV detection, especially in less well-established genes, supporting improved genetic risk assessment for MPC patients.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pathogenic-germline-variants-in-cancer-predisposition-genes-in-patients-with-multiple-primary-cancers-in-an-asian-population-and-the-role-of-extended-panel-genetic-testing/368336/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pathogenic-germline-variants-in-cancer-predisposition-genes-in-patients-with-multiple-primary-cancers-in-an-asian-population-and-the-role-of-extended-panel-genetic-testing/368336.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of evaluating pathogenic germline variants in multiple primary cancers?","Question",{"text":112,"@type":113},"The study assesses how often MPC patients carry PGVs and characterizes the spectrum of detected variants to clarify hereditary cancer predisposition risk and testing value.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were cancer patients selected and how did genetic testing differ?",{"text":117,"@type":113},"Cancer patients seen in Singapore’s cancer genetics clinic from 2000 to 2023 were included. Most underwent 49-gene testing, while 156 selected MPC patients received an extended 216-gene panel.",{"name":119,"@type":110,"acceptedAnswer":120},"What did extended panel testing change in PGV detection among MPC patients?",{"text":121,"@type":113},"Extended testing detected more PGVs even when initial testing was noninformative, increasing findings in less well-known cancer predisposition genes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368336,1790216871,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","ORIGINAL ARTICLE  \nPathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing  \nS. W. Cheo1, J. J. Zhao1, 2, 3 , 4, P. Y. Ong1, S. G. W. Ow1, C. J. L. Ow5, G. H. J. Chan1, R. J. Walsh1, J. S. J. Lim1, 2, 5, S. E. Lim1,  \nY. W. Lim1, A. L. A. Wong1, J. E.-L. Wong1 & S. C. Lee1, 2, 5 􀀁  \n1Department of Haematology-Oncology, National University Cancer Institute, Singapore; 2Yong Loo Lin School of Medicine, National University of Singapore, Singapore; 3Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore; 4Department of Medicine, National University Hospital, Singapore; 5Cancer Science Institute, National University of Singapore, Singapore  \nAvailable online xxx  \nBackground: Multiple primary cancers (MPC) are an indicator of potential hereditary cancer predisposition syndrome. There remains insufﬁcient data on genetic testing outcomes and the optimal testing panel for MPC. We evaluated the prevalence of MPC, the spectrum of pathogenic germline variants (PGVs) and the role of extended panel testing in MPC. Methods: Cancer patients seen in a cancer genetics clinic in a tertiary cancer centre in Singapore from 2000 to 2023 were included. Clinical characteristics, PGV and patterns of cancer were analysed. Most patients were tested with 49 genes, but in a selected 156 patients with MPC, extended testing with 216 genes was carried out.  \nResults: Of 3514 cancer patients (male ¼ 17.9%, female ¼ 82. 1%), 668 (19%) had MPC (2 primaries, n ¼ 570; 3 primaries, n ¼ 81; 􀀃4 primaries, n ¼ 17) . The most common tumour pairs were breastebreast (33 . 2%), breasteovary (8 .9%), breast eendometrial (4 .6%) and endometrialeovary (4 .6%) . Patients with MPC had a younger median age of ﬁrst cancer. Of the MPC patients, 29 .4% tested positive for at least one PGV, with PGVs detected in BRCA1/2 (39 .9%), other homologous recombination repair (HRR) genes (18 .9%), mismatch repair (MMR) genes (11 . 2%) and TP53 (7%) genes. HRR genes included ATM, BARD1, BRIP1, CHEK2, PALB2, FANCL, RAD51C and RAD51D, while MMR genes included MLH1, MSH2, MSH6 and PMS2 . MPC patients were more likely to have PGVs in TP53 and BARD1 compared with patients with single primary cancer. Extended testing detected more PGVs in MPC despite initial noninformative testing. It increased the number of PGVs detected in less established cancer predisposition genes, which include CFTR, SPINK1, TNFRSF13B, TET2, ADA, CDKN1C, CTNNA1, DDX41, HAX1, RECQL4 and MBD4 .  \nConclusion: Patients with MPC were more likely to harbour a PGV. Extended testing improved PGV detection rates, particularly for less well-known cancer predisposition genes.  \nKey words: multiple primary cancers, pathogenic germline variants, germline genetic testing, extended testing, hereditary cancer predisposition syndrome  \nINTRODUCTION  \nMultiple primary cancers (MPC) are deﬁned as two or more histologically distinct malignancies within one individual that are not caused by metastasis, recurrence or local progression.1 Worldwide, the frequency of MPC is reported to be in the range of 2%-17% .1 The wide range is likely due to differences in cancer registration practices, case deﬁnitions and follow-up duration.2,3  \n*Correspondence to: Prof. Dr Soo Chin Lee, Department of HaematologyOncology, National University Cancer Institute, 1E Kent Ridge Road, Singapore 119228, Singapore. Tel: þ6567737888  \nE-mail: [csilsc@nus.edu.sg](csilsc@nus.edu.sg) (S. C. Lee).  \n2059-7029/© 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \nVarious factors have been implicated in the occurrence of MPC. With better cancer therapeutics, improved survival has led to an increase in the diagnosis of MPC.4,5 Addi","cbCaiqRll4TMD7OG","https://ap.wps.com/l/cbCaiqRll4TMD7OG","pdf",17559191,"English","# Background\n# Methods\n## Study population and methods\n# Results\n# Conclusion\n# Key words","[{\"question\":\"What is the purpose of evaluating pathogenic germline variants in multiple primary cancers?\",\"answer\":\"The study assesses how often MPC patients carry PGVs and characterizes the spectrum of detected variants to clarify hereditary cancer predisposition risk and testing value.\"},{\"question\":\"How were cancer patients selected and how did genetic testing differ?\",\"answer\":\"Cancer patients seen in Singapore’s cancer genetics clinic from 2000 to 2023 were included. Most underwent 49-gene testing, while 156 selected MPC patients received an extended 216-gene panel.\"},{\"question\":\"What did extended panel testing change in PGV detection among MPC patients?\",\"answer\":\"Extended testing detected more PGVs even when initial testing was noninformative, increasing findings in less well-known cancer predisposition genes.\"}]","Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing | PDF",1790176378,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/765ce8f920bb58f096c11b6191ad887c.webp",983,1269,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24552356e3ba0eb8aa22cc785bcfaad6.webp",982,1268,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02d05dfecda2cc068d2f9131c4f5cb29.webp",981,1266,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/855c3c5dd5403ed3b755c122dc844899.webp",980,1265]